Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Gastro-Intestinal Stromal Tumour × masitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pruritus 2 Piebaldism 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mastocytosis, Systemic 2 Mastocytosis 2 Gastrointestinal Stromal Tumors 2 Blushing 2 Recurrence 1 Multiple Myeloma 1 Metastatic Castrate Resistant Prostate Cancer 1 Melanoma 1 Gastro-Intestinal Stromal Tumour 1 Colorectal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02009423 2018-12-14

Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence

AB Science

Phase 3 Terminated

Gastro-Intestinal Stromal Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡